View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | Netherlands |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2030-05-03 |
| Par Value | 100000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 650.00 |
| Coupon | 3.227 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 650.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Roche Finance Europe B.V. corporate medium term notes has a 3.23% fixed rate coupon paid on a annual basis. It was issued on May 03, 2024 with an issue size of 650.00 million EUR and matures on May 03, 2030 with a last coupon date of May 03, 2029. |
Roche Finance Europe B.V., founded in 2005 and headquartered in the Netherlands, serves as a key financing entity for the Roche Group, a global leader in pharmaceuticals and diagnostics. The company primarily focuses on issuing debt securities to support the Group's strategic initiatives and enhance its financial flexibility.